Metabolism of third generation synthetic cannabinoids using zebrafish larvae

Synthetic cannabinoids are the second largest group of new psychoactive substances reported by the United Nations Office on Drugs and Crime in the last decade and case reports bring attention to its high potency effects and its severe toxicity, including fatalities. Moreover, synthetic cannabinoids...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug testing and analysis 2022-04, Vol.14 (4), p.594-603
Hauptverfasser: Morales‐Noé, Asunción, Esteve‐Turrillas, Francesc A., Armenta, Sergio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Synthetic cannabinoids are the second largest group of new psychoactive substances reported by the United Nations Office on Drugs and Crime in the last decade and case reports bring attention to its high potency effects and its severe toxicity, including fatalities. Moreover, synthetic cannabinoids are usually entirely metabolized and metabolic pathways for many new generation synthetic cannabinoids are still unknown. In this study, the metabolism of five third generation synthetic cannabinoids was evaluated using zebrafish (Danio rerio) larvae as 24‐h in vivo model studied within 5 days after fertilization. The studied synthetic cannabinoids were MMB‐CHMICA, ADB‐CHMICA, ADB‐CHMINACA, MDMB‐CHMCZCA, and NNL‐3, and the respective metabolites were identified by liquid chromatography‐high resolution tandem mass spectrometry. Eleven, six, fourteen, eleven, and four metabolites were identified for MMB‐CHMICA, ADB‐CHMICA, ADB‐CHMINACA, MDMB‐CHMCZCA, and NNL‐3, respectively, and metabolic pathways have been proposed. The use of zebrafish larvae, with a high degree of physiological and genetic homology to humans, is an emerging tool very useful for the identification of metabolic pathways of psychoactive substances. Results obtained in this study compared well with metabolites obtained previously for the same target molecules or structural analogous after in vitro incubation with human or rat hepatocytes. Thus, potential biomarkers for the evaluated compounds are the O‐demethylated metabolite for MMB‐CHMICA; the oxidative deamination to hydroxyl metabolite for ADB‐CHMICA; hydroxyl metabolites at cyclohexylmethyl, tert‐butyl, and indazole moieties for ADB‐CHMINACA; hydroxyl metabolites at carbazole core, tert‐butyl, or cyclohexylmethyl tail moieties for MDMB‐CHMCZCA; and amide hydrolyzed, defluorinated, and dihydroxilated metabolite for NNL‐3. The metabolism pathway of MMB‐CHMICA, ADB‐CHMICA, ADB‐CHMINACA, MDMB‐CHMCZCA, and NNL‐3 synthetic cannabinoids was evaluated using zebrafish (Danio rerio) larvae as 24 h studied within 5 days after fertilization, and metabolites were identified by liquid chromatography‐high‐resolution mass spectrometry (LC‐HRMS).
ISSN:1942-7603
1942-7611
DOI:10.1002/dta.3195